Literature DB >> 6134095

Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda.

G H Elder, D M Sheppard, J A Tovey, A J Urquhart.   

Abstract

Immunoreactive uroporphyrinogen decarboxylase was measured by rocket immuno-electrophoresis in haemolysates from 7 unrelated patients with familial porphyria cutanea tarda (PCT), 6 patients with sporadic PCT, and 7 normal subjects. In all patients with familial PCT immunoreactive enzyme protein was decreased (51% of normal), to the same extent as catalytic activity (56% of normal), whereas in sporadic PCT both measurements were normal. These results show that familial PCT is commonly caused by a mutation which does not lead to the production of non-catalytic cross-reactive immunological material. Familial PCT can be distinguished from other types of PCT by a simple immunoelectrophoretic method that does not involve measurement of uroporphyrinogen decarboxylase activity and which is therefore likely to be suitable for routine diagnostic use.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134095     DOI: 10.1016/s0140-6736(83)92414-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

1.  Steady-state levels of uroporphyrinogen decarboxylase mRNA in lymphoblastoid cell lines from patients with familial porphyria cutanea tarda and their relatives.

Authors:  J L Hansen; M A Pryor; J B Kennedy; J P Kushner
Journal:  Am J Hum Genet       Date:  1988-06       Impact factor: 11.025

2.  Blood cells as markers for metabolic disorders.

Authors:  E Beutler
Journal:  Blut       Date:  1985-12

3.  The genetic basis of porphyria cutanea tarda.

Authors:  R Enriquez de Salamanca; A Olmos; M L Peña; L Berges; J Perpiñá
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

4.  Hereditary hepatic porphyria with delta aminolevulinate dehydrase deficiency: immunologic characterization of the non-catalytic enzyme.

Authors:  H de Verneuil; M Doss; N Brusco; C Beaumont; Y Nordmann
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Different types of porphyria cutanea tarda.

Authors:  M Doss; H Sauer; F Sixel-Dietrich; R von Tiepermann
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

6.  Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria.

Authors:  H de Verneuil; C Beaumont; J C Deybach; Y Nordmann; Z Sfar; R Kastally
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

7.  Isolation and identification of a cDNA clone coding for rat uroporphyrinogen decarboxylase.

Authors:  P H Romeo; A Dubart; B Grandchamp; H de Verneuil; J Rosa; Y Nordmann; M Goossens
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Assignment of human uroporphyrinogen decarboxylase (URO-D) to the p34 band of chromosome 1.

Authors:  A Dubart; M G Mattei; N Raich; D Beaupain; P H Romeo; J F Mattei; M Goossens
Journal:  Hum Genet       Date:  1986-07       Impact factor: 4.132

9.  Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication.

Authors:  F Sixel-Dietrich; M Doss
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

10.  Prevalence of the 281 (Gly----Glu) mutation in hepatoerythropoietic porphyria and porphyria cutanea tarda.

Authors:  H de Verneuil; J Hansen; C Picat; B Grandchamp; J Kushner; A Roberts; G Elder; Y Nordmann
Journal:  Hum Genet       Date:  1988-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.